EGFr, FGFr and PDGFr: Emerging Targets for Anticancer Drug Design. Journal of Cancer Research Updates, [S. l.], v. 5, n. 3, p.  99–108, 2016. DOI: 10.6000/1929-2279.2016.05.03.3. Disponível em: https://neoplasiaresearch.com/index.php/jcru/article/view/657. Acesso em: 16 apr. 2026.